Trial record 1 of 1 for:    nct01461837
Previous Study | Return to List | Next Study

Haplo T-Cell Depleted Transplantation in High-Risk Sickle Cell Disease (HaploSCD)

This study is currently recruiting participants.
Verified March 2014 by New York Medical College
Children's Hospital & Research Center Oakland
Medical College of Wisconsin
Washington University
Tufts Medical Center
University of California, San Francisco
University of California, Los Angeles
Miltenyi Biotec GmbH
Information provided by (Responsible Party):
Mitchell Cairo, New York Medical College Identifier:
First received: October 19, 2011
Last updated: March 24, 2014
Last verified: March 2014
No Study Results Posted on for this Study
  Study Status: This study is currently recruiting participants.
  Estimated Study Completion Date: April 2017
  Estimated Primary Completion Date: April 2016 (Final data collection date for primary outcome measure)